Therapeutic antibody engineering : (Record no. 39593)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | nam a22 7a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 190410b2012 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781907568374 |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615.37 STR-W |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Strohl, William R. |
| 245 ## - TITLE STATEMENT | |
| Title | Therapeutic antibody engineering : |
| Remainder of title | current and future advances driving the strongest growth area in the pharmaceutical industry / |
| Statement of responsibility, etc. | William R. Strohl and Lila M. Strohl |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | India |
| Name of publisher, distributor, etc. | Woodhead Publishing |
| Date of publication, distribution, etc. | 2012 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 650 p. |
| 365 ## - TRADE PRICE | |
| Price type code | USD |
| Price amount | 305.00. |
| 440 ## - SERIES STATEMENT/ADDED ENTRY--TITLE | |
| Title | Woodhead publishing series in Biomedicine. |
| Volume/sequential designation | 11 |
| 500 ## - GENERAL NOTE | |
| General note | The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas. Therapeutic antibody engineering examines all aspects of engineering monoclonal antibodies and analyses the effect that various genetic engineering approaches will have on future candidates. Chapters in the first part of the book provide an introduction to monoclonal antibodies, their discovery and development and the fundamental technologies used in their production. Following chapters cover a number of specific issues relating to different aspects of antibody engineering, including variable chain engineering, targets and mechanisms of action, classes of antibody and the use of antibody fragments, among many other topics. The last part of the book examines development issues, the interaction of human IgGs with non-human systems, and cell line development, before a conclusion looking at future issues affecting the field of therapeutic antibody engineering. <br/><br/>Goes beyond the standard engineering issues covered by most books and delves into structure-function relationships<br/>Integration of knowledge across all areas of antibody engineering, development, and marketing<br/>Discusses how current and future genetic engineering of cell lines will pave the way for much higher productivity |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Monoclonal antibodies--Therapeutic use |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Immunotechnology |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Biomedical engineering |
| 650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Immunoglobulins--Therapeutic use |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Strohl, Lila M. |
| 952 ## - LOCATION AND ITEM INFORMATION (KOHA) | |
| Withdrawn status | |
| Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection code | Home library | Current library | Shelving location | Date acquired | Cost, normal purchase price | Full call number | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dewey Decimal Classification | 610 | BITS Pilani Hyderabad | BITS Pilani Hyderabad | General Stack (For lending) | 10/04/2019 | 305.00 | 615.37 STR-W | 38893 | 13/07/2024 | 10/04/2019 | Books |